Successful development of therapeutic hepatitis B vaccine in China can kill virus thoroughly

Recently, according to the authoritative report of "light of science and technology" of CCTV, the anti HBV transfer factor oral liquid with independent intellectual property rights in China has been successfully developed, and has been used in more than 30 hospitals including Beijing Friendship Hospital and Beijing Ditan Hospital Affiliated to Capital Medical University The three-year experiment showed that the anti HBV transfer factor oral liquid contains high-intensity anti HBV immune active peptide substance, which has the effect of stimulating T cells to transform into HBV immune cells with super lethal effect It can kill virus cells and recover liver function, so as to cure hepatitis B completely It mainly treats big and small Sanyang, virus carrier, liver fibrosis, liver ascites and early cirrhosis It is effective for alcoholic liver and fatty liver It is a kind of safe and effective biological new drug for liver disease Patients with large and small Sanyang virus usually take one to two courses of treatment, and patients with severe hepatitis only need to take three courses of treatment It is the most ideal treatment drug for hepatitis B at present Since this high-tech achievement came into the market, it has helped many hepatitis B patients on the road of rehabilitation In order to reduce the burden of patients, the state has established 333 liver disease rehabilitation project and implemented the "buy two get one" assistance action The therapeutic hepatitis B vaccine has significant curative effect It is publicly promised that anyone who does not turn negative after taking a course of treatment will be free of drug fee for follow-up treatment until recovery.